Current methods to define metabolic tumor volume in positron emission tomography: which one is better?

HJ Im, T Bradshaw, M Solaiyappan, SY Cho - Nuclear medicine and …, 2018 - Springer
Numerous methods to segment tumors using 18 F-fluorodeoxyglucose positron emission
tomography (FDG PET) have been introduced. Metabolic tumor volume (MTV) refers to the …

The role of 18F-FDG-PET/CT in pediatric sarcoma

DJ Harrison, MT Parisi, BL Shulkin - Seminars in Nuclear Medicine, 2017 - Elsevier
Considerable debate remains regarding how best to incorporate 18 F-FDG-PET/CT into
clinical practice for pediatric sarcomas. Although there is a clear role for 18 F-FDG-PET/CT …

[HTML][HTML] Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human …

Y Liu, DB Raina, S Sebastian, H Nagesh, H Isaksson… - Acta Biomaterialia, 2021 - Elsevier
Doxorubicin (DOX) is a cornerstone drug in the treatment of osteosarcoma. However,
achieving sufficient concentration in the tumor tissue after systemic administration with few …

[HTML][HTML] A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT

K Hirata, K Kobayashi, KP Wong, O Manabe… - PloS one, 2014 - journals.plos.org
Background 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed
tomography (CT) has been an essential modality in oncology. We propose a semi …

[HTML][HTML] Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model

H Sheen, W Kim, BH Byun, CB Kong, WS Song… - PloS one, 2019 - journals.plos.org
Background Osteosarcoma (OS) is the most common primary bone tumor affecting humans
and it has extreme heterogeneity. Despite modern therapy, it recurs in approximately 30 …

[HTML][HTML] Prognostic significance of 18F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis

T Kubo, T Furuta, MP Johan, M Ochi - European Journal of Cancer, 2016 - Elsevier
Purpose The usefulness of 18 F-fluorodeoxyglucose positron emission tomography (18 F-
FDG PET) for the survival prognosis in soft tissue sarcoma (STS) and bone sarcoma (BS) is …

[PDF][PDF] PET/CT in the diagnosis and prognosis of osteosarcoma

X Zhang, Z Guan - Front Biosci (Landmark Ed), 2018 - article.imrpress.com
Osteosarcoma is an aggressive malignancy that usually occurs in children and young
adults, and long-term survival is only about 20% in patients with metastasis or recurrent …

Positron emission tomography (18) F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: a meta-analysis

YJ Li, YL Dai, YS Cheng, WB Zhang, CQ Tu - European Journal of Surgical …, 2016 - Elsevier
Purpose To investigate the prognostic significance of (18) F-FDG PET imaging in patients
with bone and soft tissue sarcoma, a meta-analysis was conducted. Methods …

PET/MRI in children

S Gatidis, B Bender, M Reimold, JF Schäfer - European Journal of …, 2017 - Elsevier
During the past decade, combined PET/MRI has been translated from a basic technical
concept to a clinical research tool and a clinically applied hybrid imaging modality …

Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18 F-FDG PET/CT and MRI

BH Byun, CB Kong, I Lim, BI Kim, CW Choi… - European journal of …, 2014 - Springer
Purpose We evaluated the potential of sequential fluorine-18 fluorodeoxyglucose (18 F-
FDG) positron emission tomography (PET)/computed tomography (CT) and MRI (PET/MRI) …